Literature DB >> 18688025

Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis.

Peter M Elias1, Jack Arbiser, Barbara E Brown, Heidemarie Rossiter, Mao-Qiang Man, Francesca Cerimele, Debra Crumrine, Roshan Gunathilake, Eung Ho Choi, Yoshikazu Uchida, Erwin Tschachler, Kenneth R Feingold.   

Abstract

Primary abnormalities in permeability barrier function appear to underlie atopic dermatitis and epidermal trauma; a concomitant barrier dysfunction could also drive other inflammatory dermatoses, including psoriasis. Central to this outside-inside view of disease pathogenesis is the epidermal generation of cytokines/growth factors, which in turn signal downstream epidermal repair mechanisms. Yet, this cascade, if sustained, signals downstream epidermal hyperplasia and inflammation. We found here that acute barrier disruption rapidly stimulates mRNA and protein expression of epidermal vascular endothelial growth factor-A (VEGF-A) in normal hairless mice, a specific response to permeability barrier requirements because up-regulation is blocked by application of a vapor-impermeable membrane. Moreover, epidermal vegf(-/-) mice display abnormal permeability barrier homeostasis, attributable to decreased VEGF signaling of epidermal lamellar body production; a paucity of dermal capillaries with reduced vascular permeability; and neither angiogenesis nor epidermal hyperplasia in response to repeated tape stripping (a model of psoriasiform hyperplasia). These results support a central role for epidermal VEGF in the maintenance of epidermal permeability barrier homeostasis and a link between epidermal VEGF production and both dermal angiogenesis and the development of epidermal hyperplasia. Because psoriasis is commonly induced by external trauma [isomorphic (Koebner) phenomenon] and is associated with a prominent permeability barrier abnormality, excess VEGF production, prominent angiogenesis, and epidermal hyperplasia, these results could provide a potential outside-inside mechanistic basis for the development of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688025      PMCID: PMC2527083          DOI: 10.2353/ajpath.2008.080088

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  81 in total

1.  The regulation of permeability barrier homeostasis.

Authors:  Kenneth R Feingold; Matthias Schmuth; Peter M Elias
Journal:  J Invest Dermatol       Date:  2007-07       Impact factor: 8.551

Review 2.  Molecular mechanisms of VEGF-A action during tissue repair.

Authors:  Sabine A Eming; Thomas Krieg
Journal:  J Investig Dermatol Symp Proc       Date:  2006-09

3.  Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis.

Authors:  Xiao-Yong Man; Xiao-Hong Yang; Sui-Qing Cai; Yong-Gang Yao; Min Zheng
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

Review 4.  The evolution of the psoriatic lesion.

Authors:  P C M van de Kerkhof
Journal:  Br J Dermatol       Date:  2007-07       Impact factor: 9.302

5.  Upregulation of hypoxia-inducible factors in normal and psoriatic skin.

Authors:  Christian Rosenberger; Caius Solovan; Alina D Rosenberger; Li Jinping; Regina Treudler; Ulrich Frei; Kai-Uwe Eckardt; Lawrence F Brown
Journal:  J Invest Dermatol       Date:  2007-05-10       Impact factor: 8.551

6.  Stratum corneum acidification is impaired in moderately aged human and murine skin.

Authors:  Eung-Ho Choi; Mao-Qiang Man; Pu Xu; Shujun Xin; Zhili Liu; Debra A Crumrine; Yan J Jiang; Joachim W Fluhr; Kenneth R Feingold; Peter M Elias; Theodora M Mauro
Journal:  J Invest Dermatol       Date:  2007-06-07       Impact factor: 8.551

7.  Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function.

Authors:  Heidemarie Rossiter; Caterina Barresi; Minoo Ghannadan; Florian Gruber; Michael Mildner; Dagmar Födinger; Erwin Tschachler
Journal:  FASEB J       Date:  2007-07-11       Impact factor: 5.191

Review 8.  Mouse models of psoriasis.

Authors:  Johann E Gudjonsson; Andrew Johnston; Melissa Dyson; Helgi Valdimarsson; James T Elder
Journal:  J Invest Dermatol       Date:  2007-04-12       Impact factor: 8.551

Review 9.  Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis.

Authors:  Aileen Sandilands; Frances J D Smith; Alan D Irvine; W H Irwin McLean
Journal:  J Invest Dermatol       Date:  2007-06       Impact factor: 8.551

Review 10.  Immunopathogenesis of psoriasis.

Authors:  Robert Sabat; Sandra Philipp; Conny Höflich; Stefanie Kreutzer; Elizabeth Wallace; Khusru Asadullah; Hans-Dieter Volk; Wolfram Sterry; Kerstin Wolk
Journal:  Exp Dermatol       Date:  2007-10       Impact factor: 3.960

View more
  32 in total

1.  Selenium unmasks protective iron armor: A possible defense against cutaneous inflammation and cancer.

Authors:  Jack L Arbiser; Michael Y Bonner; Nicole Ward; Justin Elsey; Shikha Rao
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-05-28       Impact factor: 3.770

Review 2.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

3.  Epidermal permeability barrier recovery is delayed in vitiligo-involved sites.

Authors:  J Liu; W Y Man; C Z Lv; S P Song; Y J Shi; P M Elias; M Q Man
Journal:  Skin Pharmacol Physiol       Date:  2010-02-25       Impact factor: 3.479

Review 4.  Human skin models: From healthy to disease-mimetic systems; characteristics and applications.

Authors:  Tânia Moniz; Sofia A Costa Lima; Salette Reis
Journal:  Br J Pharmacol       Date:  2020-08-19       Impact factor: 8.739

5.  Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment.

Authors:  Benjamin P Davis; Emily M Stucke; M Eyad Khorki; Vladislav A Litosh; Jeffrey K Rymer; Mark Rochman; Jared Travers; Leah C Kottyan; Marc E Rothenberg
Journal:  JCI Insight       Date:  2016-04

6.  Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions.

Authors:  John R Zibert; Katrin Wallbrecht; Margarete Schön; Lluis M Mir; Grete K Jacobsen; Veronique Trochon-Joseph; Céline Bouquet; Louise S Villadsen; Ruggero Cadossi; Lone Skov; Michael P Schön
Journal:  J Clin Invest       Date:  2010-12-06       Impact factor: 14.808

7.  Expression of Angiogenic Factors in Psoriasis Vulgaris.

Authors:  Lakshna Sankar; Dhanalakshmi Arumugam; Sudha Boj; Priyanka Pradeep
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  Persistent inflammation and angiogenesis during wound healing in K14-directed Hoxb13 transgenic mice.

Authors:  Judith A Mack; Edward V Maytin
Journal:  J Invest Dermatol       Date:  2009-09-17       Impact factor: 8.551

9.  VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury.

Authors:  Lyn M Wise; Gabriella S Stuart; Nicola C Real; Stephen B Fleming; Andrew A Mercer
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-08-01       Impact factor: 4.730

10.  Let it flow: Morpholino knockdown in zebrafish embryos reveals a pro-angiogenic effect of the metalloprotease meprin alpha2.

Authors:  André Schütte; Jana Hedrich; Walter Stöcker; Christoph Becker-Pauly
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.